Go Back
10x Genomics, Inc. reports $50.7 million Q1 loss
By USInMinutes - May 03, 2023, 05:24 PM ET
Last Updated - Jul 18, 2023, 03:41 PM EDT
The company generated $134.30 million in quarterly revenue
10x Genomics, Inc. [TXG] has reported fiscal Q1 loss of $50.70 million.
On a per-share basis, the DE based company said its diluted earnings are $0.44.
The Laboratory Analytical Instruments firm posted revenue of $134.30 million in this period.
Also Read:
- 10x Genomics Reports First Quarter 2023 Financial Results
- 10x Genomics to Present at the BofA Securities 2023 Healthcare Conference
- 10x Genomics to Present at the BofA Securities 2023 Healthcare Conference
- 10x Genomics to Report First Quarter 2023 Financial Results on May 3, 2023
- 10x Genomics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Outlook for 2023
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Sponsored
Sponsored
Read More from Investing
Popular News
Latest News